Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Nemucore Remove


December 2014
Mo Su Sa Fr Th We Tu
22 21 20 19 18 17 16

nemucore Press Releases

  + XML/RSS  



By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

All Press Releases

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

By Nemucore Medical Innovations, Inc.
NMI's Co-Founder Dr. Torchilin was named the recipient of the Journal of Drug Targeting’s Lifetime Achievement Award for 2012 for his work in multifunctional pharmaceutical nanocarriers.

By Nemucore Medical Innovations
Nemucore Medical Innovations, as part of Northeastern University’s Center of Cancer Nanotechnology Excellence (CCNE) consortium, will develop nanomedicine manufacturing processes under recent $13.5 million grant from the National Cancer Institute



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share